Effects of Targeted Acupuncture Methods Alongside Infrared Therapy on Symptom Relief and Quality of Life in Individuals with Allergic Rhinitis - Scorecard - MDSpire
Clinical Scorecard: Effects of Targeted Acupuncture Methods Alongside Infrared Therapy on Symptom Relief and Quality of Life in Individuals with Allergic Rhinitis
At a Glance
Category
Detail
Condition
Allergic Rhinitis
Key Mechanisms
Acupuncture at specific acupoints (BL7 and BL11) combined with infrared irradiation.
Target Population
Individuals with allergic rhinitis.
Care Setting
Clinical trial setting.
Key Highlights
Significant reduction in Total Nasal Symptom Score (TNSS) and Total Non-Nasal Symptom Score (TNNSS) in the study group.
Improvement in quality of life as measured by the Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ).
Lower incidence of adverse reactions in the acupuncture group compared to loratadine.
Significant decreases in serum IgE levels and inflammatory markers (IL-4, IL-6, IFN-γ) in the study group.
Standardized acupuncture protocol shows promise as a non-pharmacological treatment option.
Guideline-Based Recommendations
Diagnosis
Assess allergic rhinitis symptoms and consider patient history.
Management
Consider acupuncture combined with infrared therapy as an adjunct to conventional pharmacotherapy.
Monitoring & Follow-up
Evaluate symptom scores (TNSS, TNNSS) and quality of life (RQLQ) at multiple time points.
Risks
Monitor for potential adverse reactions such as drowsiness and dry mouth.
Patient & Prescribing Data
120 patients with allergic rhinitis.
Acupuncture with infrared therapy showed superior efficacy compared to loratadine alone.
Clinical Best Practices
Implement standardized acupuncture protocols for consistency in treatment outcomes.
Integrate complementary therapies like acupuncture in managing chronic allergic conditions.
The 2025 US Department of Veterans Affairs and US Department of Defense asthma guideline introduces 21 evidence-based recommendations for primary care, redefining stepwise treatment, comorbidity management, and reliever strategy.
A cross-sectional metagenomic study found greater oral microbiome richness among adults with chronic rhinosinusitis, particularly nonallergic chronic rhinosinusitis, while associations with asthma, airway inflammation, and most lung-function measures were inconsistent.
A phase 2 randomized trial suggests reducing nasal commensal viruses with ribavirin spray may improve allergic rhinitis symptoms while supporting a proposed disease mechanism.
